Literature DB >> 23928992

Cyclin D1-dependent induction of luminal inflammatory breast tumors by activated notch3.

Hua Ling1, Jean-René Sylvestre, Paul Jolicoeur.   

Abstract

Accumulating evidence suggests that Notch3 (N3) is involved in breast cancer development, but its precise contributions are not well understood. Here, we report that pregnant mice expressing an activated intracellular form of N3 (N3(IC)) exhibit a cyclin D1-dependent expansion of premalignant CD24(+) CD29(low) luminal progenitors with enhanced differentiation potential in vitro and in vivo. Parous mice developed luminal mammary tumors in a cyclin D1-dependent manner. Notably, mice expressing higher levels of N3(IC) exhibited tumors resembling inflammatory breast cancer that frequently metastasized. N3(IC)-induced tumors contained a large percentage of tumor-initiating cells, but these were reduced significantly in tumors derived from N3(IC) transgenic mice that were heterozygous for cyclin D1. After transplantation in the presence of normal mammary cells, N3(IC)-expressing tumor cells became less malignant, differentiating into CK6(+) CK18(+) CK5(-) alveolar-like structures akin to expanded luminal progenitors from which they were likely derived. Taken together, our results argue that activated N3 signaling primarily affects luminal progenitors among mammary cell subsets, with more pronounced levels of activation influencing tumor type, and provide a novel model of inflammatory breast cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23928992     DOI: 10.1158/0008-5472.CAN-13-0409

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

Review 1.  Form and function: how estrogen and progesterone regulate the mammary epithelial hierarchy.

Authors:  Lisa M Arendt; Charlotte Kuperwasser
Journal:  J Mammary Gland Biol Neoplasia       Date:  2015-07-19       Impact factor: 2.673

2.  A phase I, dose-escalation study of PF-06650808, an anti-Notch3 antibody-drug conjugate, in patients with breast cancer and other advanced solid tumors.

Authors:  Lee S Rosen; Robert Wesolowski; Raffaele Baffa; Kai-Hsin Liao; Steven Y Hua; Brenda L Gibson; Steven Pirie-Shepherd; Anthony W Tolcher
Journal:  Invest New Drugs       Date:  2019-03-18       Impact factor: 3.651

3.  NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non-inflammatory breast cancers.

Authors:  François Bertucci; Charlotte Rypens; Pascal Finetti; Arnaud Guille; José Adélaïde; Audrey Monneur; Nadine Carbuccia; Séverine Garnier; Piet Dirix; Anthony Gonçalves; Peter Vermeulen; Bisrat G Debeb; Xiaoping Wang; Luc Dirix; Naoto T Ueno; Patrice Viens; Massimo Cristofanilli; Max Chaffanet; Daniel Birnbaum; Steven Van Laere
Journal:  Mol Oncol       Date:  2020-02-05       Impact factor: 6.603

4.  Runx2 is a novel regulator of mammary epithelial cell fate in development and breast cancer.

Authors:  Thomas W Owens; Renee L Rogers; Sarah Best; Anita Ledger; Anne-Marie Mooney; Alison Ferguson; Paul Shore; Alexander Swarbrick; Christopher J Ormandy; Peter T Simpson; Jason S Carroll; Jane Visvader; Matthew J Naylor
Journal:  Cancer Res       Date:  2014-07-23       Impact factor: 12.701

5.  Cellular senescence checkpoint function determines differential Notch1-dependent oncogenic and tumor-suppressor activities.

Authors:  S Kagawa; M Natsuizaka; K A Whelan; N Facompre; S Naganuma; S Ohashi; H Kinugasa; A M Egloff; D Basu; P A Gimotty; A J Klein-Szanto; A J Bass; K-K Wong; J A Diehl; A K Rustgi; H Nakagawa
Journal:  Oncogene       Date:  2014-06-16       Impact factor: 9.867

6.  A synthetic triterpenoid CDDO-Im inhibits tumorsphere formation by regulating stem cell signaling pathways in triple-negative breast cancer.

Authors:  Jae Young So; Janice J Lin; Joseph Wahler; Karen T Liby; Michael B Sporn; Nanjoo Suh
Journal:  PLoS One       Date:  2014-09-17       Impact factor: 3.240

7.  Function of Integrin-Linked Kinase in Modulating the Stemness of IL-6-Abundant Breast Cancer Cells by Regulating γ-Secretase-Mediated Notch1 Activation in Caveolae.

Authors:  En-Chi Hsu; Samuel K Kulp; Han-Li Huang; Huang-Ju Tu; Santosh B Salunke; Nicholas J Sullivan; Duxin Sun; Max S Wicha; Charles L Shapiro; Ching-Shih Chen
Journal:  Neoplasia       Date:  2015-06       Impact factor: 5.715

8.  Aberrations of Chromosomes 1 and 16 in Breast Cancer: A Framework for Cooperation of Transcriptionally Dysregulated Genes.

Authors:  Anna Provvidenza Privitera; Vincenza Barresi; Daniele Filippo Condorelli
Journal:  Cancers (Basel)       Date:  2021-03-30       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.